<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Telomeres are the repeat DNA sequences at the end of chromosomes necessary for successful DNA replication and chromosomal integrity </plain></SENT>
<SENT sid="1" pm="."><plain>Telomeres shorten at cell division at a rate determined by oxidative DNA damage, and cells are triggered into replicative senescence once telomeres shorten to a critical length </plain></SENT>
<SENT sid="2" pm="."><plain>Telomere-related chromosomal maintenance also has a role in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is characterised by increased <z:mp ids='MP_0003674'>oxidative stress</z:mp>, increased oxidative DNA damage, senescent <z:chebi fb="46" ids="15035">retinal</z:chebi> and renal phenotypes, and an increased risk of epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We suggest that increased oxidative DNA damage and telomere attrition in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> leads to: (1) carcinogenic telomere-dependent chromosomal non-reciprocal translocations, genomic instability, and the development of epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>; (2) senescent <z:chebi fb="46" ids="15035">retinal</z:chebi> and renal phenotypes (expressed as diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and <z:hpo ids='HP_0000112'>nephropathy</z:hpo>); and (3) senescent vascular endothelial, monocyte-macrophage and vascular smooth muscle cells (expressed as <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> and accelerated atherogenesis) </plain></SENT>
<SENT sid="5" pm="."><plain>An adverse intrauterine environment leads to increased feto-placental <z:mp ids='MP_0003674'>oxidative stress</z:mp> and feto-placental oxidative DNA damage </plain></SENT>
<SENT sid="6" pm="."><plain>We also suggest that intrauterine oxidative DNA damage and telomere shortening is another point at which increased <z:mp ids='MP_0003674'>oxidative stress</z:mp> could contribute to a pre-programmed increased risk of senescent phenotypes in adult offspring, characterised by type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These suggestions can be used to understand early <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> in the young children of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> pregnancies, poor <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> outcomes in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, beta cell <z:mp ids='MP_0002899'>fatigue</z:mp> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the absence of increased epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>